How One Regional Health System Reduced Pharmacy Spend by 12%

Health systems sit in a unique position. They are both a provider of care and an employer funding care for their members. They often operate in-house pharmacies and employ prescribing physicians. Yet, many struggle to control the rising costs of specialty medications for their employee populations.

When internal pharmacy operations, drug sourcing, and vendor contracts operate in silos, financial waste can occur. Here is how one prominent regional health system transformed its pharmacy plan management to regain control and lower costs.

The Challenge: Misaligned Strategies and Rising Costs

Supporting 13,400 plan members, this regional health system faced a daunting financial outlook. Despite robust internal capabilities, their annualized pharmacy spend was increasing rapidly. Upon analyzing utilization data, the root cause became clear: misaligned strategies.

Their on-site pharmacies operated in silos, entirely disconnected from the broader health plan strategy. Furthermore, the organization struggled with complex specialty drug flows. Specialty medications accounted for a massive portion of total pharmacy spend, but members accessed high-cost treatments through fragmented channels. This created severe inefficiencies and inflated claims costs. Finally, existing vendor contracts lacked the rigorous oversight required to secure competitive pricing.

The health system needed a strategic overhaul to unify its in-house operations with aligned vendor contracting and clinical oversight.

The Solution: An Integrated Pharmacy Benefits Model

The root cause of the health system’s escalating costs was not a lack of resources, but a lack of integration. To solve this, the health system partnered with RxBenefits to design a fully integrated pharmacy benefits model. This comprehensive approach focused on optimizing four critical pillars:

1. Aligning in-house pharmacies: By incenting plan members to fill their prescriptions internally, the system retained revenue that would have otherwise gone to external retail chains. This had the impact of simultaneously lowering total drug costs for the pharmacy benefits plan.

2. Optimizing specialty drug sourcing: Clinical experts evaluated the system’s specialty medication routing. New protocols ensured high-cost specialty drugs were sourced through the most cost-effective channels available. This approach prioritized the health system’s internal specialty pharmacy capabilities whenever clinically appropriate.

3. Implementing independent utilization review: To prevent wasteful spending, clinical pharmacists conducted peer reviews of high-cost claims. This evidence-based program drove meaningful improvements in member health by ensuring every prescribed specialty drug was clinically necessary and dispensed at the optimal dosage.

4. Strategic vendor contracting: By leveraging collective purchasing power, the health system renegotiated its vendor contracts. This strategic savings approach combined pharmacy benefits manager (PBM) negotiation with transparent pricing models, eliminating hidden margins and securing a fair price for every dispensed medication.

The Impact: Financial Control and Sustained Care Quality

The results of this strategic integration were immediate and profound. In the first year alone, the health system achieved a 12% reduction in total pharmacy spend. For an organization supporting 13,400 members, this represented millions of dollars in recovered capital.

Beyond immediate financial savings, the unified strategy stopped revenue leakage and improved overall profitability. The independent clinical review process insulated the plan from the volatility of specialty drug price hikes. Most importantly, these massive savings were achieved without compromising access or quality of care. Members received the precise treatments they needed with streamlined, coordinated access.

Actionable Insights for Your Plan

This success story illustrates a vital lesson for self-funded employers: escalating pharmacy costs are not inevitable. They are often the result of operational inefficiencies. For health systems specifically, directing member utilization to in-house pharmacies can keep dollars within their organization.

Important insights for other self-funded employers include:

Prior independent clinical review: An independent partner can delve deeper into clinical data to identify optimization opportunities for specialty medications.
Demand contract transparency: Ensure your vendor contracts align with your financial goals.
Focus on integration: Align drug sourcing, clinical review, and vendor contracting into a single cohesive strategy to avoid financial waste.

Is your plan overpaying for pharmacy benefits due to misaligned strategies or fragmented specialty drug routing? It might be time to look closer at an integrated benefits model.

Visit the RxBenefits blog each month to read more success stories!

Stay informed: sign up for our newsletter for expert advice and actionable insights about the pharmacy benefits industry.

Learn more: